Cargando…

Integrated Analysis Identifies an Immune-Based Prognostic Signature for the Mesenchymal Identity in Gastric Cancer

BACKGROUND: Gastric cancer (GC) has been divided into four molecular subtypes, of which the mesenchymal subtype has the poorest survival. Our goal is to develop a prognostic signature by integrating the immune system and molecular modalities involved in the mesenchymal subtype. METHODS: The gene exp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Dongzhu, Gu, Bin, Ruan, Liming, Zhang, Xingguo, Shu, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171688/ https://www.ncbi.nlm.nih.gov/pubmed/32352015 http://dx.doi.org/10.1155/2020/9780981

Ejemplares similares

Integrated analysis identifies an immune-based prognostic signature for the mesenchymal identity in colorectal cancer
por: Zhang, Bin, et al.
Publicado: (2020)

Integrative network analysis identifies an immune-based prognostic signature as the determinant for the mesenchymal subtype in epithelial ovarian cancer
por: Sheng, Mingyan, et al.
Publicado: (2020)

Immune signature profiling identified prognostic factors for gastric cancer
por: Yang, Wenhui, et al.
Publicado: (2019)

Prognostic implications of an autophagy-based signature in colorectal cancer
por: Wang, Liangbin, et al.
Publicado: (2021)

An immune-related gene signature predicts prognosis of gastric cancer
por: Jiang, Bitao, et al.
Publicado: (2019)

Gene pair based prognostic signature for colorectal colon cancer
por: Shu, Peng, et al.
Publicado: (2018)

An immune-related prognostic signature associated with immune landscape and therapeutic responses in gastric cancer
por: Sun, Jian-Rong, et al.
Publicado: (2023)

Integrated Analysis Identifies Molecular Signatures and Specific Prognostic Factors for Different Gastric Cancer Subtypes()
por: Min, Li, et al.
Publicado: (2016)

A vasculogenic mimicry prognostic signature associated with immune signature in human gastric cancer
por: Wang, Jie, et al.
Publicado: (2022)

Integrating the Epigenome and Transcriptome of Hepatocellular Carcinoma to Identify Systematic Enhancer Aberrations and Establish an Aberrant Enhancer-Related Prognostic Signature
por: Huang, Peng, et al.
Publicado: (2022)

Establishment of a Prognostic Signature of Stromal/Immune-Related Genes for Gastric Adenocarcinoma Based on ESTIMATE Algorithm
por: Yu, Shan, et al.
Publicado: (2021)

Immunogenomic Landscape and Immune-Related Gene-Based Prognostic Signature in Asian Gastric Cancer
por: Mao, Chenchen, et al.
Publicado: (2021)

Integrative analysis identifies an immune-relevant epigenetic signature for prognostication of non-G-CIMP glioblastomas
por: Yin, Anan, et al.
Publicado: (2021)

Lipid metabolism characterization in gastric cancer identifies signatures to predict prognostic and therapeutic responses
por: Zeng, Jiawei, et al.
Publicado: (2022)

Whole-exome sequencing identifies prognostic mutational signatures in gastric cancer
por: Zhu, Zhenxin, et al.
Publicado: (2020)

Integrated bioinformatic analysis identified a novel prognostic pan-programmed cell death signature for bladder cancer
por: Zhang, Lusi, et al.
Publicado: (2022)

Integrative Network Analysis Reveals a MicroRNA-Based Signature for Prognosis Prediction of Epithelial Ovarian Cancer
por: Li, Li, et al.
Publicado: (2019)

An individualized immune prognostic signature in lung adenocarcinoma
por: Sun, Liangdong, et al.
Publicado: (2020)

Comprehensive Analysis to Identify the Epithelial–Mesenchymal Transition-Related Immune Signatures as a Prognostic and Therapeutic Biomarkers in Hepatocellular Carcinoma
por: Wu, Guozhi, et al.
Publicado: (2021)

Integrative network biology analysis identifies miR-508-3p as the determinant for the mesenchymal identity and a strong prognostic biomarker of ovarian cancer
por: Zhao, Linjie, et al.
Publicado: (2018)

Integrated single-cell and bulk RNA sequencing in pancreatic cancer identifies disulfidptosis-associated molecular subtypes and prognostic signature
por: Wu, Yunhao, et al.
Publicado: (2023)

An integrated genomic analysis of anaplastic meningioma identifies prognostic molecular signatures
por: Collord, Grace, et al.
Publicado: (2018)

Integrated Analysis to Identify a Redox-Related Prognostic Signature for Clear Cell Renal Cell Carcinoma
por: Wu, Yue, et al.
Publicado: (2021)

Prognostic value of gastric cancer‐associated gene signatures: Evidence based on a meta‐analysis using integrated bioinformatics methods
por: Wang, Jun, et al.
Publicado: (2018)

Identification and prognostic value of metabolism-related genes in gastric cancer
por: Wen, Fang, et al.
Publicado: (2020)

A Fourteen Gene GBM Prognostic Signature Identifies Association of Immune Response Pathway and Mesenchymal Subtype with High Risk Group
por: Arimappamagan, Arivazhagan, et al.
Publicado: (2013)

Prognostic Value of microRNA Signature in Patients with Gastric Cancers
por: Liu, Hai-Ting, et al.
Publicado: (2017)

Correction: Integrative network biology analysis identifies miR-508-3p as the determinant for the mesenchymal identity and a strong prognostic biomarker of ovarian cancer
por: Zhao, Linjie, et al.
Publicado: (2019)

Development and Validation of a Robust Immune-Related Prognostic Signature for Gastric Cancer
por: Huo, Junyu, et al.
Publicado: (2021)

Clinical significance and prognostic role of an immune-related gene signature in gastric adenocarcinoma
por: Mao, Rui, et al.
Publicado: (2021)

CBXs-related prognostic gene signature correlates with immune microenvironment in gastric cancer
por: Zhang, Yin Jiang, et al.
Publicado: (2022)

Integrated Bioinformatics Analysis for Identifying the Significant Genes as Poor Prognostic Markers in Gastric Adenocarcinoma
por: Li, Yamei, et al.
Publicado: (2022)

Immune gene prognostic signature for disease free survival of gastric cancer: Translational research of an artificial intelligence survival predictive system
por: Zhang, Zhiqiao, et al.
Publicado: (2021)

Immune landscape and prognostic immune-related signature in KRAS-mutated lung adenocarcinoma
por: Peng, Xinyi, et al.
Publicado: (2023)

An integrated analysis of prognostic mRNA signature in early- and progressive-stage gastric adenocarcinoma
por: Hong, Xiaoling, et al.
Publicado: (2023)

Identification of a novel 10 immune‐related genes signature as a prognostic biomarker panel for gastric cancer
por: Chen, Tingna, et al.
Publicado: (2021)

Development and Experimental Validation of a Novel Prognostic Signature for Gastric Cancer
por: Liu, Chengcheng, et al.
Publicado: (2023)

Identification and Validation of Immune- and Stemness-Related Prognostic Signature of Melanoma
por: Zhang, Yan, et al.
Publicado: (2021)

Laryngeal Squamous Cell Carcinoma: Potential Molecular Mechanism and Prognostic Signature Based on Immune-Related Genes
por: Mo, Bin-Yu, et al.
Publicado: (2020)

Tumor Immune Microenvironment Landscape in Glioma Identifies a Prognostic and Immunotherapeutic Signature
por: Zhang, Chunyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k0ibkto68qqu6p8q9rtm51mqfi